Page 1553 - Hematology_ Basic Principles and Practice ( PDFDrive )

1380 Part VII Hematologic Malignancies

Willemze R, Kerl H, Sterry W, et al: EORTC classification for primary natural killer (NK)/T-cell lymphoma, nasal type: the NK-Cell Tumor
cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Study Group study. J Clin Oncol 29:4410, 2011.
Group of the European Organization for Research and Treatment of Yoo HY, et al: A recurrent inactivating mutation in RHOA GTPase in
Cancer. Blood 90:354, 1997. angioimmunoblastic T cell lymphoma. Nat Genet 46(4):371–375, 2014.
Wu P, Kim YH, Lavori PW, et al: A meta-analysis of patients receiving Zinzani PL, Baliva G, Magagnoli M, et al: Gemcitabine treatment in pre-
allogeneic or autologous hematopoietic stem cell transplant in mycosis treated cutaneous T-cell lymphoma: experience in 44 patients. J Clin
fungoides and Sézary syndrome. Biol Blood Marrow Transplant 15:982, Oncol 18:2603, 2000.
2009. Zinzani PL, Bonthapally V, Huebner D, et al: Panoptic clinical review of the
Yamaguchi M, Kwong YL, Kim WS, et al: Phase II study of SMILE chemo- current and future treatment of relapsed/refractory T-cell lymphomas:
therapy for newly diagnosed stage IV, relapsed, or refractory extranodal Peripheral T-cell lymphomas. Crit Rev Oncol Hematol 99:214–227, 2016.